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Background. Plasma membrane NCX1 Na1/Ca21 exchangers
mediate cellular Ca21 efflux. Renal distal convoluted tubule
(DCT) cells express transcripts encoding three alternatively
spliced NCX1 isoforms: NACA2 (exons B, C, D), NACA3 (exons
B and D), and NACA6 (exons A, C, D). We used antisense
oligodeoxynucleotides (ODNs) to determine the function of these
NACA isoforms on Na1/Ca21 exchanger activity and expression
in DCT cells.
Methods. Sense and antisense ODNs targeting exchanger tran-
scripts were introduced into DCT cells permeabilized with strep-
tolysin O. Na1/Ca21 exchange activity was assessed by measuring
Na1-dependent changes of free intracellular Ca21 concentration
(D[Ca21]i), in single cells, when the electrochemical gradient for
Na1 was reversed.
Results. The change of [Ca21]i in cells treated with antisense
ODNs to a downstream or upstream region common to all NCX1
isoforms was 173 nM (266%) to the downstream region located in
the putative ninth transmembrane domain, and 226 nM (239%)
with ODNs to an upstream region located 59 to the variable
portion of the intracellular loop. Antisense ODNs to exon B,
present in both NACA2 and NACA3, decreased D[Ca21]i by 209
nM (244%), while antisense ODNs specific for NACA6 (exon A)
were without effect. Antisense ODNs specific for exon C, present
in NACA2 and NACA6, decreased D[Ca21]i by 226 nM (239%).
Northern analysis of mRNA prepared from primary cultures of
distal tubule cells revealed exon B- but not exon A-containing
transcripts. Immunofluorescence analysis using a polyclonal anti-
body that recognizes NCX1 confirmed that protein expression was
inhibited after treatment with the exon B antisense ODNs.
Conclusion. These findings show that Na1-dependent cellular
Ca21 efflux in DCT cells is primarily mediated by NACA2 and
NACA3.
Na1/Ca21 exchange mediates Ca21 efflux in nonpolar-
ized cells and in polarized epithelial cells [1]. In the kidney,
Na1/Ca21 exchange is a major mechanism for cellular
calcium extrusion by distal convoluted tubules (DCT) and
connecting tubules [2–4], the principal nephron sites of
regulated calcium transport. DCT cells express transcripts
encoding three alternatively spliced NCX1 isoforms:
NACA2 (exons B, C, D), NACA3 (exons B and D), and
NACA6 (exons A, C, D) [5–8]. The NCX1 gene encodes a
Na1/Ca21 exchanger that is highly conserved across species
and is expressed in kidney [4, 7], as well as in heart [9, 10],
and in brain [11]. Transcripts for two additional genes
encoding Na1/Ca21 exchangers, NCX2 and NCX3, were
not detected in kidney RNA by Northern analysis [12, 13].
Genomic cloning of a variable region within a large intra-
cellular loop demonstrated that as many as 32 different
NCX1 exchanger isoforms arise from alternative splicing in
this region [14]. The variable region contains six exons
designated A–F, with exons A and B being mutually
exclusive, while exons C–F are of the cassette type [14].
Renal tissues largely express exon B-containing transcripts
and one or more cassette exons. Rabbit and rat kidneys
express isoforms NACA2 (exons B, C, and D), NACA3 (B
and D), and NACA7 (B, D, and F) [6, 15, 16]. The role of
individual Na1/Ca21 exchanger isoforms in mediating
plasma membrane Ca21 efflux in tubular epithelial cells is
not known.
We previously reported the partial cloning of NCX1
transcripts encoding a downstream region of the exchanger
that is present in all exchanger isoforms, as well as the
variable regions of NACA2, NACA3, and NACA6 (exons
A, C, and D) from a mouse cell line that possesses a DCT
phenotype [8]. These cells exhibit robust Na1/Ca21 ex-
change activity [8]. The aim of the present studies was to
identify the Na1/Ca21 exchanger isoforms responsible for
mediating Na1-dependent, plasma membrane Ca21 efflux
in DCT cells by using antisense oligodeoxynucleotides
(ODNs).
METHODS
Cell culture
Immortalized mouse DCT cells were derived from a
mixed population of cortical ascending limb (CAL) and
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DCT cells that were immunologically isolated using Tamm-
Horsfall protein antiserum [17]. Primary cultures of these
cells were immortalized by exposure to chimeric adenovirus
12-simian virus 40 (AD12/SV40) and subcloned by limiting
dilution. DCT cells exhibit an appropriate phenotype,
including thiazide-sensitive Na1:Cl2 cotransport [18] and
parathyroid hormone-stimulated cAMP formation [19]. In
some experiments we used primary cultures of distal tubule
cells, which are designated as such in the text. These refer
to the hybrid population of DCT and CAL cells grown in
tissue culture, whereas DCT cells are the clonal, immortal-
ized cells. Primary cell cultures were prepared for each
experiment in which they were used.
Cells were grown on 100-mm dishes (Corning Glass
Works, Corning, NY, USA) in DME/Ham’s F12 media
(Sigma, St. Louis, MO, USA) supplemented with 5%
heat-inactivated (56°C for 20 min) fetal calf serum (Sigma)
and an antibiotic mixture (50 mg penicillin, 50 mg strepto-
mycin, 100 mg neomycin/100 ml media; Gibco, Gaithers-
burg, MD, USA) in a humidified atmosphere of 95%
O2/5% CO2 at 37°C. Primary cultures of distal tubule cells
were cultured under the same conditions, except in 10%
fetal calf serum. To improve cell adhesion to glass slides, on
the day of isolation primary cultures of distal tubule cells
were plated on 100-mm plastic tissue culture dishes for 18
hours, then trypsinized, pelleted, resuspended in complete
medium, and dispersed on glass coverslips or glass slides for
subsequent measurement of intracellular Ca21 or indirect
immunofluorescence analysis.
Measurement of intracellular Ca21 and reverse Na1/Ca21
exchange activity
The concentration of free intracellular Ca21 ([Ca21]i)
was measured in single DCT cells using procedures de-
tailed elsewhere [20, 21]. Briefly, cells grown on 25-mm
diameter glass cover slips were incubated for 60 minutes at
37°C with 10 mM fura-2 AM (Molecular Probes, Eugene,
OR, USA). The cells were then rinsed several times and
placed in a perfusion chamber thermostated to 37°C
mounted on the stage of an inverted microscope (Nikon,
Melville, NY, USA). Emitted fluorescence was measured
with a Nikon Photoscan-2.
Na1/Ca21 exchange activity was analyzed by measuring
Na1-dependent changes of [Ca21]i after the transmem-
brane electrochemical gradient for Na1 was reversed. This
was accomplished by increasing [Na1]i by treating cells with
the Na1 ionophore, monensin (1 mM) in the presence of
140 mM Na1 and with 1 mM ouabain for 15 minutes.
Nifedipine (10 mM) was included in all solutions to exclude
Ca21 entry. Cells were then exposed to a Na1-free buffer,
where Na1 was isosmotically replaced with tetramethylam-
monium (TMA). The experimental protocol consisted of
an initial two minutes baseline period, 15 minutes incuba-
tion with the Na1 buffer, five minutes with the Na1-free
buffer followed by calibration [18]. Fluorescence emission
was monitored at a rate of 1/second. The Na1-dependent
rise of [Ca21]i was calculated from the difference of [Ca
21]i
between a plateau phase after the addition of ouabain and
nifedipine in the presence of extracellular Na1 and the
peak of [Ca21]i after removal of extracellular Na
1. The
average of values of [Ca21]i during 30 seconds immediately
before switching to TMA was used to calculate the plateau,
and a 30 seconds window encompassing the peak response
of [Ca21]i after switching to TMA was used to calculate the
maximal response [22, 23].
Oligodeoxynucleotide treatments
Twenty base pair sense or antisense ODNs (Macromo-
lecular Resources, Ft. Collins, CO, USA) were designed to
mouse DCT cell NCX1 isoform cDNA sequences. Fully
phosphorothioate derivatized ODNs were used because of
their increased half-life in cells compared to partial or
nonderivatized phosphorothioate ODNs [24–26]. Se-
quences of sense and antisense ODNs are given in Table 1.
ODNs were introduced into DCT or primary cultures of
distal tubule cells by brief permeabilization with streptoly-
sin O [27]. Approximately 50,000 to 100,000 cells were
trypsinized and resuspended in 0.5 ml permeabilization
buffer consisting of (in mM): 137 NaCl, 100 Pipes, 5.6
glucose, 2.7 KCl, 2.7 EGTA, 1 ATP, 0.1% bovine serum
albumin) adjusted to pH 7.4, and containing 20 units of
streptolysin O/ml and 100 nM ODN, unless otherwise
stipulated. After a 10 minutes incubation at 37°C, 5 ml of
DME/Ham’s F-12 medium containing 5% fetal calf serum
were added to stop the permeabilization reaction.
Table 1. Sequences of sense and antisense oligonucleotides targeting
NCX1 transcripts
Region or exon Sequence, 59 3 39
Conserved downstream region
sense AAAGATTCCGTGACTGCCGT
Conserved downstream region
antisense ACGGCAGTCACGGAATCTTT
Conserved upstream region
sense ACATTTGAGGAACCCGTGAC
Conserved upstream region
antisense GTCACGGGTTCCTCAAATGT
Exon A
sense CTTCATTGAGATTGGAGAGC
antisense GCTCTCCAATCTCAATGAAG
Exon B
sense AGTTTCTCCCTTGTGCTTGA
antisense TCAAGCACAAGGGAGAAACT
Exon C
sense GCCCTGTTGTTGAATGAGCT
antisense AGCTCATTCAACAACAGGGC
Exon F
sense CCATGCTAGAGATCATCCGAT
antisense ATCGGATGATCTCTAGCATGG
Sequences of antisense and sense oligodeoxynucleotides to conserved
and variable regions of the NCX1 Na1/Ca21 exchanger transcript are
shown.
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RNA isolation
Primary cultures of distal tubule cells (23107) cells were
washed twice with 5 ml 13 Ca21/Mg21-free Hank’s bal-
anced salt solution. Cells were directly solubilized in 1.0 ml
1 M GITC, layered onto a 1.5 ml CsCl gradient in 3 ml
TL-100 centrifuge tubes (Beckman, Fullerton, CA, USA)
and overlaid with 0.15 ml 20% sarkosyl (sodium N-
dodecanoyl-N-methylglycinate). Gradients were centri-
fuged for two hours at room temperature. Pellets were
washed with 70% ethanol and resuspended in 100 ml sterile
water. Quantitation of yield was determined by absorbance
at 260 nm and 280 nm. Poly (A)1 RNA was isolated from
total cellular RNA by oligo-dT chromatography [Poly (A)
Quick Kit, Stratagene, La Jolla, CA, USA].
cDNA probes
NCX1 cDNA probes were prepared by RT-PCR ampli-
fication of mouse brain and kidney mRNAs with primers
specific for exons A and exon B (Table 2). The primers
were designed from the cDNA sequences of the variable
intracellular region of mouse NCX1 [8]. The mRNA was
reverse transcribed using MuMLV reverse transcriptase
and random hexamers (Gene Amp RNA-PCR Kit; Perkin-
Elmer, Foster City, CA, USA) for 10 minutes at room
temperature, then 15 minutes at 42°C, in the presence of 5
mM MgCl2. The reaction was terminated by heating to 99°C
for five minutes. The cDNA was then amplified in the same
tubes by PCR with Taq polymerase (Perkin-Elmer). PCR
was performed at 94°C for one minute, annealed at 45°C,
and extended for two minutes at 70°C for 35 cycles, with a
final extension of seven minutes. The products were sepa-
rated by electrophoresis on a 1% low-melting agarose gel
(FMC, Rockland, ME, USA) and stained with ethidium
bromide. cDNA products (100 ng) were directly sequenced
using 3.2 pM of the forward or reverse PCR primers with
the PRISM DyeDeoxy Sequencing Kit (ABI, Foster City,
CA, USA). Sequence comparisons between subcloned
cDNA products and previously identified sequences were
carried out with GCG (Genetics Computer Group, Madi-
son, WI, USA) and GeneWorks (IntelliGenetics, Mountain
View, CA, USA) software.
Northern analysis
mRNA was separated by electrophoresis on a 1% aga-
rose/formaldehyde gel and electrotransferred overnight to
GeneScreen Plus (DuPont NEN, Wilmington, DE, USA).
Membranes were prehybridized in a solution of 1 M NaCl,
1% SDS, and 10% dextran sulfate for 60 minutes at 55°C.
The blot was probed with 2 3 106 cpm/ml of the randomly
primed (Prime-it II Kit; Stratagene), [32P]dCTP-labeled
(6000 Ci/mmol; DuPont NEN) exon A or exon B PCR
products, or a 400 bp cDNA probe encoding mouse NCX1
transmembrane domains 7 to 10 [8], the region homologous
to amino acids 785 to 903 of the canine cardiac exchanger
[9]. The blots were washed at high stringency with 50 ml 23
SSC, 0.1% SDS three times at room temperature, then with
0.13 SSC, 0.1% SDS four times at 50°C and exposed to
Kodak X-AR film for one to seven days at 270°C. For
Northern analyses the specific activity for the exon A probe
was 6,559 dpm/ng cDNA; for the exon B probe it was 5,468
dpm/ng, and for the 400 bp common probe it was 41,028
dpm/ng.
Immunofluorescence
Primary cultures of distal tubule cells were grown on
8-well chamber slides (Becton Dickinson, Franklin Lakes,
NJ, USA) in 0.7 ml DMEM/F12 supplemented with 10%
fetal bovine serum. Slides were rinsed 3 times with 0.5 ml
13 TBS pH 7.4 and then fixed for 20 minutes at room
temperature in 0.5 ml 100% methanol. The slides were
rinsed four times with 0.5 ml 13 TBS and blocked 18 hours
in 5% BLOTTO. Samples were analyzed with a 1:50
dilution of a polyclonal antibody to a portion of the rabbit
NCX1 Na1/Ca21 exchanger [7] applied in 5% BLOTTO for
two hours. The slides were washed three times with 5%
BLOTTO for 15 minutes. A FITC conjugated, goat sec-
ondary antibody to guinea pig IgG (Cappel, Durham, NC,
USA) was applied at a 1:100 dilution for 60 minutes in the
dark.
After incubation with the secondary antibody, the slides
were washed three times for 10 minutes each in the dark
with 13 TBS pH 7.4. Hoechst 33342 dye (Sigma), 2.0
mg/ml, which intercalates with the minor groove of DNA,
was then applied for 15 minutes to stain nuclei, followed by
two five-minute washes with 13 PBS. Coverslips were
mounted in the presence of an antiquench solution (1,4
diazabicyclo- [2.2.2]octane (Sigma), 1 mg/ml in PBS/glycer-
ol; 1/10, vol:vol). Cells were visualized with a Nikon Micro-
phot FXA microscope using a FITC-specific filter (NCX1
analysis) or, for the Hoechst dye, with a filter set comprised
of a 330 to 380 nm excitation filter in series with a 510 nm
dichroic mirror and a 420 nm longpass emission filter.
Exposure durations were established for control condi-
tions; sense and antisense ODN-treated cells were photo-
graphed using the identical aperture and exposure with a
Table 2. Oligodeoxynucleotide primers used for amplification of exon
A and exon B by PCR
Primer Sequence, 59 3 39 Annealing Temp. (°C)
Exon AF AATATCAGTCAAGGTAATCG 45
Exon AR CTTCTCACTCATCTCCACCA
Exon BF AACGATGAAATAGTGAAGAT 45
Exon BR ATCCTCTTCTTAGCCATTTT
The sequences of the primers used for amplification of exon A and exon
B by polymerase chain reaction (PCR) from partially cloned mouse NCX1
isoforms are shown. The annealing temperature for each primer pair is
shown in the right hand column. “F” indicates the forward primer and “R”
indicates the reverse primer for each pair.
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computer-driven Nikon FX-35DX camera and Fujichrome
Provia 1600 ASA film.
Statistical analysis
Effects of experimental treatments were assessed by
paired comparisons within experiments and reported as the
mean 6 SE of N independent experiments. Comparisons
between control and experimental treatment groups were
evaluated by analysis of variance and post-hoc analysis of
multiple comparisons using the Bonferroni method (Instat;
Graph-Pad, San Diego, CA, USA). Curve fitting was
performed by a least squares method using Prism software
(Graph-Pad). Values of P # 0.05 were assumed to be
significant.
RESULTS
Analysis of Na1/Ca21 exchange using antisense to
common portions of NCX1
Antisense oligodeoxynucleotides (ODNs) were used to
relate the expression of Na1/Ca21 exchange transcripts in
DCT cells with functional, plasma membrane Na1/Ca21
exchange activity. Two independent antisense and sense
ODNs (Table 1) were designed from conserved sequences
present in all NACA2, NACA3, and NACA6 NCX1 iso-
forms. The first was to an upstream region of the exchanger
transcript located 59 to the variable portion of the intracel-
lular loop, and the second was to a downstream region
located in the putative ninth transmembrane domain.
ODNs were introduced into DCT cells by a brief perme-
abilization with streptolysin O. Control cells were perme-
abilized but not treated with ODNs. Eighteen to 24 hours
after the ODN treatment, the reverse Na1/Ca21 exchange
activity was analyzed by measuring the Na1-dependent
changes of [Ca21]i in single DCT cells. Figure 1 shows
illustrative traces for each treatment condition. Compared
to control or sense ODN-treated cells, the rise of [Ca21]i
upon reversal of the Na1 gradient was blunted in cells
treated with antisense ODNs. The average results of three
experiments for each condition are shown in Figure 2 and
the data are summarized in Table 3. Hatched bars denote
the results for the upstream ODNs and the filled bars those
for the downstream ODNs. In cells treated with an anti-
sense ODN targeted to the downstream region, the rise of
[Ca21]i was reduced from 510 to 173 nM, a decrease of 66%
(P , 0.01) compared to control cells or cells treated with
the sense ODN. In cells treated with antisense ODNs
targeting the upstream region, the rise of [Ca21]i was only
226 nM, a decrease of 39% (P , 0.01) compared to control.
There were no statistically significant differences in the
resting levels of [Ca21]i between treatments.
Isoform-specific antisense effects on exchange activity
To characterize the participation of individual Na1/Ca21
exchanger isoforms, exon-specific antisense oligonucleo-
tides were designed to the three isoforms, NACA2,
NACA3, and NACA6 (Table 3). Exchange activity was
analyzed as described above and the results are summa-
rized in Figure 3 and Table 4. Antisense oligonucleotides
targeting exon A, present only in NACA6, had no effect on
the rise of [Ca21]i compared to control or sense ODN-
treated cells. Antisense ODNs directed to exon B, present
in NACA2 and NACA3, however, inhibited the rise of
[Ca21]i by 44% (P , 0.01) compared to sense ODN-treated
or control cells.
As displayed in Figure 3 and summarized in Table 4,
antisense ODNs to exon C, expressed in both NACA2 and
NACA6, resulted in a 39% decrease in the rise of [Ca21]i
(P , 0.01) compared to the control and sense-treated DCT
cells. Because ODNs to exon A, which is present only in
NACA6, had no effect on exchange activity, antisense
targeted to exon C presumably inhibited NACA2. It is
unlikely that the antisense ODNs to exon B inhibited exon
C or vice versa since there is no sequence homology
between these two exons in the region of ODN targeting.
We also tested exon F, which is present in the renal isoform
NACA7 [16] cloned from a rat cDNA library but not found
Fig. 1. Na1-dependent changes of intracellular
calcium ([Ca21]i) in single distal convoluted
tubule (DCT) cells. Representative traces of
[Ca21]i in cells treated with antisense or sense
oligodeoxynucleotides (ODNs) or permeabilized
but not exposed to ODNs. [Ca21]i was
measured in single cells after reversing the
direction of Na1/Ca21 exchange. In the reverse
mode, an outwardly directed Na1 gradient
energizes Ca21 influx. Intracellular Na1 was
raised by blocking the Na1,K1-ATPase and
changes of [Ca21]i in single cells were examined
in the absence of extracellular Na1 with the
Ca21-sensitive dye fura-2. Cells treated with the
antisense ODNs (Antisense) designed to a
downstream region of the NCX1 transcript
present in NACA2, NACA3, and NACA6
cloned from DCT cells showed a smaller rise of
[Ca21]i compared to the cells not exposed to
ODNs (Control) or sense ODNs (Sense).
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in DCT cells. Antisense ODNs targeted to exon F had no
significant effect on Na1/Ca21 exchange compared the
response observed with sense-treated or control cells (Ta-
ble 4).
Exon A and exon B expression in distal tubule cell NCX1
mRNAs
Initial studies of NCX1 in DCT cells uncovered a single
NACA6 (exons A, C, D) isoform out of 20 clones [8],
consistent with the low abundance of exon A-containing
transcripts. Because antisense ODNs targeting exon A had
no effect on Na1/Ca21 exchange activity in DCT cells (Fig.
3), we could not verify that they possessed biological
activity. Since, to our knowledge, mouse cell lines exclu-
sively expressing exon A-containing transcripts do not exist,
Northern analysis was performed to determine if exon A-
or exon B-containing exchanger transcripts could be de-
tected in primary cultures of distal tubule cells, which
express greater levels of NCX1 than immortalized DCT
cells [8]. mRNA prepared from mouse kidney and distal
tubule cells, as well as from brain, which served as a positive
control, was analyzed with cDNA probes to either mouse
exon A, exon B, or to a common region present in all
isoforms homologous to the region encoding NCX1 trans-
membrane domains 7 to 10 [8]. The exon A probe hybrid-
ized with a 7 kB transcript in brain (Fig. 4, Exon A),
consistent with reports that brain primarily expresses exon
A NCX1 isoforms [11, 14]. Kidney and distal tubule cells
were negative for exon A (Fig. 4, Exon A). The exon B
probe hybridized to transcripts present in kidney and distal
tubule cells, but was negative for brain (Fig. 4, Exon B).
These observations agree with reports that exon B is
expressed in kidney [6, 15, 28], and the fact that exon
B-containing transcripts were the predominant clones in
the DCT cell line [8]. The probe to the common domain
hybridized to a 7 kB transcript in all mRNAs (Fig. 4,
Common), indicating that NCX1 mRNA was readily de-
tectable and that the RNA samples were intact. The probe
also hybridized to a 14 kB band previously reported in renal
tissue [29] that may be pre-spliced mRNA (Fig. 4, Com-
mon). The greater intensity of the bands in the samples
analyzed with the common region probe is most likely due
to its higher specific activity compared to exon A or exon B
probes (Methods section).
The observation that exon B but not exon A transcripts
were detected in kidney and distal tubule cell RNA,
together with the presence of a single NACA6 clone from
DCT cells, indicates that the relative abundance of exon
A-containing transcripts is low in DCT cells relative to the
Fig. 2. Effects of ODNs targeted to conserved
portions of NCX1 on Na1/Ca21 exchange
activity. The rise of [Ca21]i was assessed as
described in the legend to Table 3. The average
results of 3 experiments for downstream and
upstream ODNs targeting common sites present
within all DCT NCX1 isoforms is shown. The
NCX1 structural model shown in the inset
depicts the position of the upstream ODNs
within the large intracellular loop adjacent to
the open boxed variable region (o) and
downstream ODNs in the putative ninth
transmembrane domain (filled transmembrane
segment). Antisense ODNs inhibited the rise of
[Ca21]i in DCT cells by 39% for the upstream
ODN (o) and by 66% for the downstream
ODN (f). Control and sense ODN-treated cells
displayed no significant differences in the rise
of [Ca21]i between either set of ODNs. *P ,
0.01 versus respective control.
Table 3. Summary of effects of antisense ODNs to conserved regions
of the Na1/Ca21 exchanger on reverse Na1/Ca21 exchange activity
Downstream
ODN
Upstream
ODN
D[Ca21]i , nM
Control 510 6 20 370 6 54
Sense 397 6 27 408 6 27
Antisense 173 6 39a 226 6 19a
Values are the means 6 SE of 3 independent experiments each for
control and sense oligodeoxynucleotides (ODNs) and 4 for the antisense
ODNs with both downstream and upstream sequences. Fluorescence
emission was monitored at a rate of 1/second. The values represent the
difference of [Ca21]i between a plateau phase after addition of ouabain
and nifedipine in the presence of extracellular Na1, and the peak after
removal of extracellular Na1. The average of values of [Ca21]i during 30
seconds immediately prior to switching to Na1-free solution was used to
calculate the plateau, and a 30 second window encompassing the peak
response of [Ca21]i was used to calculate the maximal response [22, 23].
a P , 0.01 vs. Control
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number of exon B-containing transcripts. Therefore, these
results are compatible with the view that suppression of
exon A-containing NCX1 isoforms (NACA6) may have no
discernible effect on Na1/Ca21 exchange activity in DCT
cells because the exon B-containing exchangers (NACA2
and NACA3) are the dominant isoforms and their activities
Fig. 3. Analysis of isoform-specific
oligonucleotide effects. The inset shows the
exon composition of the NCX1 isoforms studied.
DCT cells were treated with sense ODNs (f),
or antisense ODNs (M) targeting exon A,
present in NACA6, exon B, present in NACA2
and 3, or exon C, present in NACA2 and 6.
Antisense ODNs to exon B and to exon C
inhibited the rise of [Ca21]i by '40%, whereas
antisense ODNs designed to exon A also had
no effect. Control and sense-treated cells
showed no difference in the rise of [Ca21]i for
ODNs targeting exon A, B, or C. * P , 0.01
versus Control (p).
Fig. 4. Northern analysis of mRNA isolated from primary cultures of distal tubule cells. Poly (A)1 RNA (3 mg) from mouse kidney (K), brain (B),
or primary cultures of distal tubule cells (DT), was probed with the randomly-primed and [32P]dCTP-labeled mouse exon A, exon B, or common region
cDNAs. Exon A: The exon A probe revealed a 7 kB transcript in brain but not in kidney or distal tubule cells. Exon B: The exon B probe showed a 7
kB transcript in kidney and in distal tubule cells but not in brain. Common: The probe to a conserved region common among the NCX1 exchanger
isoforms revealed a 7 kB transcript in all mRNAs as well as a 14 kB transcript in distal tubule cell mRNA.
Table 4. Summary of effects of exon-specific antisense ODNs on reverse Na1/Ca21 exchange
Exon A Exon B Exon C Exon F
D[Ca21]i, nM
Sense 514 6 138 393 6 31 396 6 36 490 6 39
Antisense 431 6 30 209 6 24a 226 6 11a 387 6 17
Values are the means of SE of 3 to 5 experiments for each ODN. The experiments were performed in separate series. Control D[Ca21]i averaged 371 6
32 nM in the exon A, B and C experiments, and 432 6 36 nM in the exon F experiments.
a P , 0.01 vs. Control
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may mask the effects of ablating exon A-containing ex-
changers.
Analysis of ODN effects on NCX1 exchanger protein
expression
To estimate the change of NCX1 protein after ODN
treatment, pilot studies were performed to identify maxi-
mal dose- and time-dependent effects on Na1/Ca21 ex-
change activity. DCT cells were treated with 1 to 1000 nM
sense or antisense exon B ODNs and assayed for reverse
exchange activity after 24 hours (Fig. 5A). Antisense ODNs
to exon B caused a dose-dependent inhibition of Na1/Ca21
exchange, and the maximal inhibition was observed at 300
nM. The sense ODN had negligible effects up to 1,000 nM.
To determine the time of maximum inhibition, DCT cells
were treated with 300 nM exon B sense or antisense ODNs
and assayed for exchange activity at times between 6 to 72
hours (Fig. 5B). Maximal inhibition of '50% occurred
after 24 to 32 hours of antisense ODN treatment. Sense
ODNs exhibited negligible effects over this time course.
Based upon these findings, subsequent experiments to
characterize the effect of exon B antisense ODNs on
Na1/Ca21 exchange protein levels used 300 nM ODNs for
24 to 36 hours.
NCX1 protein is expressed at low levels in immortalized
DCT cells, making detection by immunofluorescence im-
practical. Further, NCX1 protein is downregulated in pri-
mary cell cultures grown for one week [8, 29]. However,
NCX1 protein is expressed at readily detectable levels when
primary cell cultures are grown for up to 48 hours [8] and
Northern analysis (Fig. 4) establishes that primary cultures
of distal tubule cells express exon B-containing Na1/Ca21
exchanger transcripts. Therefore, primary cultures of distal
tubule cells, no more than 48 hours after isolation, were
used for analysis of antisense ODN effects on NCX1
protein levels.
Antisense ODNs to exon B inhibited Na1/Ca21 ex-
change activity in primary cultures of distal tubule cells in a
manner indistinguishable from that in DCT cells (not
shown). Na1/Ca21 exchanger expression was assessed by
indirect immunofluorescence using a characterized poly-
clonal antibody [7] that recognizes NCX1 protein by West-
ern analysis of plasma membranes from distal tubule cells
[8] and by immunofluorescence in kidney sections [7]. The
antibody was prepared from a fusion protein encoding a
highly conserved portion of the large intracellular loop
outside the variable region [7]. Though not explicitly estab-
lished, it is assumed that it reacts to an antigenic epitope
expressed in all isoforms. As shown in Figure 6, NCX1
exchanger levels in the antisense ODN-treated cells were
dramatically decreased compared to the control or sense
ODN-treated cells, which showed no changes in fluorescent
signals (green membrane fluorescence). Hoechst staining
revealed uniformly intense nuclear labeling in all treatment
conditions (blue nuclear fluorescence), indicating the pres-
ence of distal tubule cells when NCX1 expression was
undetectable after antisense ODN treatment. As an inter-
nal control, levels of the a1 subunit of the Na1, K1-ATPase
were similarly assessed by immunofluorescence with a
Texas Red-conjugated secondary antibody and were com-
parable in distal tubule cells regardless ODN treatment
condition (not shown). These results are consistent with the
interpretation that inhibition of exchange activity by anti-
sense ODNs to exon B is due to the specific downregulation
Fig. 5. Effects of exon-specific antisense oligodeoxynucleotides (ODNs)
to the Na1/Ca21 exchanger. (A) Dose-response effects of ODNs targeting
exon B. DCT cells were treated with 1 to 1000 nM sense (f) or antisense
() ODNs and assessed for reverse exchange activity after 24 hours. The
results are plotted as the percent change of [Ca21]i under reverse
exchange conditions with either the sense or antisense ODNs compared to
control cells, which averaged 572 nM. (B) Time-dependent effects of
ODNs targeting exon B. DCT cells were treated at time 0 with 300 nM
sense (f) or antisense (F) ODNs targeting exon B and assayed for reverse
exchange activity at the indicated times. The control changes of [Ca21]i
were: 656, 439, 400, 554, 469, and 521 nM for the 6, 12, 24, 32, 48 and 72
hour treatments, respectively. Maximal inhibition of exchange activity
occurred after 24 to 32 hours of antisense treatment and returned to
control levels by 48 to 72 hours.
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of plasma membrane Na1/Ca21 exchanger protein expres-
sion.
DISCUSSION
Na1/Ca21 exchange is a major cellular calcium efflux
pathway in both polarized and nonpolarized eukaryotic
cells [30]. In polarized epithelial cells, such as those form-
ing the distal nephron, Na1/Ca21 exchange participates in
net transepithelial calcium absorption. Several Na1/Ca21
exchanger isoforms (NACA2, NACA3, and NACA6) have
been identified in the kidney, where they appear to be
expressed largely, if not entirely, in the distal convoluted
tubule and connecting tubule [3, 31]. A host of studies have
analyzed the functional properties of Na1/Ca21 exchange
[2–4], while others have documented the presence of the
protein and, more recently, multiple NCX1 isoforms in
kidney [5, 6, 16, 32, 33]. The objective of the present study
was to relate the functional activity with particular isoforms
that mediate plasma membrane Na1/Ca21 exchange by
using antisense ODNs.
We found that antisense ODNs targeting two domains
common to all cloned DCT cell NCX1 transcripts, one in
the intracellular loop and the other in a putative transmem-
brane domain, inhibited Na1/Ca21 exchange activity by 40
to 60% (Fig. 1 and Table 3). Use of exon specific antisense
ODNs targeted to NCX1 isoforms expressed in the kidney
suggest that NACA2 (exons B, C, D) and NACA3 (exons
B, D), but not NACA6 (exons A, C, D) or NACA7 (exons
B, D, F), mediate Na-dependent calcium extrusion by
Na1/Ca21 exchange (Fig. 3 and Table 4). Antisense treat-
ment was shown to suppress the expression of the ex-
changer protein markedly and specifically (Fig. 6).
Although Na1/Ca21 exchange activity was significantly
suppressed after antisense ODN treatment, the inhibition
was incomplete (Figs. 2 and 3; Tables 3 and 4). The
maximal level of inhibition achieved with antisense ODNs
is limited by several inherent and experimental factors.
First, if the rate of turnover of extent Na1/Ca21 exchangers
is slow, that is, the protein has a long half life, then it is
possible that protein in the plasma membrane or nascent
protein in the process of translation at the time of ODN
exposure could be functional when the cells were assayed
for activity at 18 to 24 hours. Second, reduction of the
intracellular ODN by nuclease degradation and dilution by
cell division may contribute to incomplete inhibition. Third,
not all of the ODN introduced into the cytoplasm may be
available for hybrid depletion. Thus, some of the ODN may
be sequestered within cytosolic compartments [34], thereby
resulting in only partial inhibition. Finally, about 30% of
the rise of [Ca21]i during reverse Na
1/Ca21 exchange in
DCT cells is not due to Ca21 entry mediated by the
exchanger [8] and is likely due to Ca21 release from
intracellular stores. This component of the rise of [Ca21]i is
most likely not due to plasma membrane Na1/Ca21 ex-
change and therefore may not inhibitable by antisense
ODN targeting NCX1.
Antisense ODNs to exon B, present in NACA2 and
NACA3, produced similar inhibition of Na1/Ca21 ex-
change activity as did ODNs to conserved isoform regions
(Tables 3 and 4). These findings reinforce the results of the
subcloning experiments showing that NACA2 and NACA3
are the dominant exchanger isoforms in DCT cells [8]. It is
not known at this time, however, if the relative abundance
of NACA2 and NACA3 mRNA transcripts is reflected in
proportionate levels of protein expression. Differences in
translational efficiency or stability could obviate, reverse, or
amplify at the protein level the modest differences of
Na1/Ca21 exchanger isoform message. To our knowledge,
there are no specific antibodies to NACA2 and NACA3
that would permit direct comparison of isoform mRNA and
protein levels.
Targeting exons B or C with antisense ODNs yielded
comparable inhibition of Na1/Ca21 exchange as observed
with antisense ODNs to conserved Na1/Ca21 exchange
sequences (Tables 3 and 4). This may indicate the presence
of undefined molecular interactions between exchanger
Fig. 6. Antisense inhibition of NCX1 protein expression in primary cultures of distal tubule cells. Primary cultures of distal tubule cells were analyzed
for the expression of NCX1 protein by indirect immunofluorescence with a FITC-conjugated secondary antibody after treatment with sense (Sense) or
antisense (Antisense) ODNs to exon B, or permeabilization in the absence of ODNs (Control). To confirm the presence of distal tubule cells, Hoechst
dye was used to co-stain nuclei. NCX1 protein was virtually abolished in cells treated with antisense ODN-treated cells. The inset bar represents 20 mm.
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isoforms and will require further study. If the functional
exchanger were an oligomer of multiple NCX1 isoforms,
decreasing the expression of any one isoform would be
expected to inhibit aggregate exchanger activity and would
explain why ODNs targeting exon B or C exhibited similar
inhibition. In addition, if ODNs are active within the
nucleus and hybridize to pre-spliced RNAs, all NCX1
transcript expression could potentially be inhibited. This
would cause downregulation of all exchanger isoforms
regardless of the exon that was targeted and produce
similar inhibition of exchanger activity. However, inhibition
of pre-spliced RNA is unlikely in the present studies since
antisense ODNs to exons A and F failed to inhibit exchange
activity (Table 4). Moreover, antisense ODNs directed
against the low-expression NACA6 isoform (exons A, C, D)
exerted no detectable decrease of the rise of [Ca21]i,
consistent with the idea that inhibition of pre-spliced RNA
is not the basis for the similar inhibition observed with
exon-specific antisense ODNs. Conversely, the present
results may indicate that ODNs inhibit expression after
RNA splicing because targeting exon F did not inhibit
Na1/Ca21 exchange.
In conclusion, we used antisense ODNs to assess the
participation of discrete Na1/Ca21 exchanger isoforms in
mediating Ca21 efflux in DCT cells, which express multiple
NCX1 isoforms produced by alternative splicing. Use of
antisense ODNs implicated NACA2 and NACA3 in medi-
ating Na1-dependent calcium efflux. Treatment with anti-
sense ODNs also specifically reduced expression of the
plasma membrane Na1/Ca21 exchanger. These studies
provide direct evidence that the Na1/Ca21 exchangers
expressed by DCT cells mediate Na1-dependent calcium
efflux. Na1-dependent cellular Ca21 efflux in clonal DCT
cells is primarily mediated by NACA2 and NACA3. These
exchangers could therefore play a role in hormone or
drug-dependent Ca21 absorption.
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